arrow
M

Michael Kabesch

children’s hospital
H指数:66
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influence of infant fucosyltransferase polymorphisms on the association of maternal secretor status with child outcomes: the Ulm birth cohort studies

婴儿岩藻糖基转移酶多态性对母体分泌者状态与儿童结局关联的影响:乌尔姆出生队列研究

2025-11-180
OAAI
Severe asthma in children and adolescents. Summary of the S1 guidelines under the auspices of the Society for Pediatric Pulmonology (GPP), AWMF register nr. 026/027

儿童和青少年重度哮喘。在德国儿科肺脏学会(GPP)赞助下制定的S1指南摘要,AWMF注册号026/027。

2025-11-010
OAAI
Complementary Predictors for Asthma Attack Prediction in Children: Salivary Microbiome, Serum Inflammatory Mediators, and Past Attack History

哮喘发作预测的补充预测因子:唾液微生物组、血清炎症介质和既往发作史

2025-08-180
OAAI
Metabotypes are linked to uncontrolled childhood asthma, gut microbiota, and systemic inflammation

代谢表型与未控制儿童哮喘、肠道微生物群和系统性炎症相关。

2025-04-230
OAAI
RSV is the main cause of severe respiratory infections in infants and young children in Germany - data from the prospective, multicenter PAPI study 2021-2023
2025-02-190
OAAI
Epigenome-Wide Association Study of Asthma Exacerbations in Europeans

哮喘急性加重在欧洲人群中的全基因组甲基化关联研究

2025-02-050
PRE
Association of Corticosteroid Inhaler Type with Saliva Microbiome in Moderate-to-Severe Pediatric Asthma
2025-01-020
OAAI
Exhaled Volatile Organic Compounds for Asthma Control Classification in Children with Moderate to Severe Asthma Results from the SysPharmPediA Study

呼出挥发性有机化合物用于中度至重度哮喘儿童的哮喘控制分类来自SysPharmPediA研究的结果

2024-11-013
PRE
Salivary microbiome as a prognostic biomarker for asthma attacks in children: results from a machine-learning approach in the SysPharmPediA study
2024-10-300
PRE
Ethnic disparities in asthma burden and gut bacteriome profiles of children with moderate-to-severe asthma in Europe
2024-10-300
PRE
Connecting the salivary microbiome and blood epigenome with a machine learning interaction approach in children with moderate-to-severe asthma
2024-10-300
PRE
Association of corticosteroid inhaler type with saliva microbiome in moderate-to-severe pediatric asthma
2024-10-300
PRE
Association of blood inflammatory endotypes and asthma burden in moderate-to-severe pediatric asthma
2024-10-300
PRE